CUV clinuvel pharmaceuticals limited

Ann: Change in substantial holding, page-14

  1. 898 Posts.
    lightbulb Created with Sketch. 373

    anyone prepared to have a guess at the half yearly financials? Here are some numbers I made up.



    EXECUTIVE SUMMARY

    Results: Half Year to 31 December 2024

    • Revenues up 6%
    • Net assets increased 7%; cash and term deposits up 8% from 30 June 2023 to $198m
    • NPBT $14.8m, unchanged
    • NPAT $10m,

    • All figures reported in Australian dollars, $


    31 December 24

    31 December 2023

    31 December 2022

    Change

    1

    Revenues, $

    34,000,000

    32,256,885

    29,355,042

    6%

    2

    Expenses, $

    23,000,000

    20,924,198

    16,376,227

    10%

    3

    Net Profit before tax, $

    14,800,000

    14,805,699

    14,599,951

    0%

    4

    Net Profit after tax, $

    10,000,000

    10,936,043

    11,387,665

    -4.0%

    5

    Basic earnings per share, $

    0.21

    0.22

    0.23

    -3.9%

    6

    Cash and term deposits, $

    198,000,000

    174,449,193

    156,813,537*

    +11.2%*

 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
$9.81
Change
-0.020(0.20%)
Mkt cap ! $491.7M
Open High Low Value Volume
$9.89 $9.99 $9.66 $899.3K 91.51K

Buyers (Bids)

No. Vol. Price($)
1 10000 $9.76
 

Sellers (Offers)

Price($) Vol. No.
$9.84 1739 2
View Market Depth
Last trade - 16.10pm 16/06/2025 (20 minute delay) ?
CUV (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.